A.G. Scientific, Inc. Cediranib (AZD2171) C-2261

Description
Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.
Description
Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.

Suppliers

Company
Product
Description
Supplier Links
A.G. Scientific, Inc.
San Diego, CA, USA
Cediranib (AZD2171)
C-2261
Cediranib (AZD2171) C-2261
Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.

Cediranib (AZD2171) is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.

Supplier's Site

Technical Specifications

  A.G. Scientific, Inc.
Product Category Biological Materials
Product Number C-2261
Product Name Cediranib (AZD2171)
Unlock Full Specs
to access all available technical data

Similar Products